| Product Code: ETC13279392 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global HER2 Testing Market was valued at USD 1.5 Billion in 2024 and is expected to reach USD 2.5 Billion by 2031, growing at a compound annual growth rate of 6.30% during the forecast period (2025-2031).
The Global HER2 Testing Market is experiencing significant growth due to the rising prevalence of HER2-positive breast cancer cases worldwide. HER2 testing is crucial for determining treatment options, as HER2-positive tumors require targeted therapies such as Herceptin. The market is driven by advancements in diagnostic technology, increasing awareness about personalized medicine, and the growing demand for accurate and reliable testing methods. Additionally, the rise in cancer incidence rates, particularly in developing regions, is contributing to the market expansion. Key players in the market are focusing on developing innovative HER2 testing solutions to cater to the evolving needs of healthcare providers and patients. Overall, the Global HER2 Testing Market is expected to continue growing as precision medicine gains prominence in cancer treatment strategies.
The Global HER2 testing market is experiencing significant growth driven by the increasing prevalence of HER2-positive cancers, particularly breast cancer. The market is witnessing a shift towards more personalized treatment approaches, with HER2 testing playing a crucial role in determining the most effective treatment options for patients. Opportunities in the market include the development of innovative HER2 testing technologies that offer higher sensitivity and accuracy, as well as the expansion of testing services in emerging markets with growing healthcare infrastructure. Additionally, the rising adoption of targeted therapies and the integration of HER2 testing into standard cancer treatment protocols are expected to further drive market growth. Overall, the Global HER2 testing market presents lucrative opportunities for companies offering advanced testing solutions and services to cater to the evolving needs of healthcare providers and patients.
The Global HER2 Testing Market faces several challenges, including the high cost associated with HER2 testing procedures and treatments, particularly in developing countries where access to advanced healthcare services may be limited. Additionally, there is a lack of standardization in HER2 testing methods, leading to variability in results and potential misdiagnosis. Limited awareness about HER2 testing among patients and healthcare providers also poses a challenge in timely and accurate testing. Furthermore, the increasing demand for personalized medicine and targeted therapies requires continuous advancements in HER2 testing technologies to ensure precise and effective treatment strategies. Overcoming these challenges will be crucial for the Global HER2 Testing Market to meet the growing demand for accurate diagnosis and personalized cancer treatments.
The Global HER2 Testing Market is primarily driven by the increasing incidence of breast and gastric cancers, as HER2 testing plays a crucial role in determining the appropriate treatment strategy for patients with these types of cancers. The rising awareness among healthcare professionals and patients about the importance of HER2 testing in personalized medicine is also fueling market growth. Technological advancements in HER2 testing methods, such as the development of more accurate and efficient testing kits, are further driving market expansion. Additionally, the growing demand for targeted therapies and precision medicine in cancer treatment is boosting the adoption of HER2 testing. Overall, the increasing focus on early and accurate diagnosis of HER2-positive cancers is expected to continue propelling the growth of the Global HER2 Testing Market in the coming years.
Government policies related to the Global HER2 Testing Market vary by country but generally focus on ensuring the accuracy and reliability of HER2 testing procedures to guide treatment decisions for breast cancer patients. Regulatory bodies such as the FDA in the United States and the European Medicines Agency in the EU have established guidelines for HER2 testing methods and companion diagnostic tests to assess HER2 status. These policies aim to standardize testing protocols, promote quality control measures, and ensure that patients receive appropriate targeted therapies based on their HER2 status. Additionally, government initiatives may support research and development efforts to improve HER2 testing technologies and promote access to testing services for patients. Overall, government policies play a crucial role in shaping the landscape of the Global HER2 Testing Market by safeguarding testing quality and facilitating the adoption of precision medicine approaches in breast cancer treatment.
The Global HER2 Testing Market is projected to experience steady growth in the coming years due to the increasing prevalence of HER2-positive cancers, such as breast and gastric cancers, as well as the growing emphasis on personalized medicine. Technological advancements in HER2 testing methods, including the development of more accurate and efficient testing platforms, are expected to drive market expansion. Additionally, the rising awareness about the importance of early detection and targeted therapies for HER2-positive cancers among healthcare providers and patients will further contribute to market growth. The market is also likely to benefit from the expanding healthcare infrastructure in emerging economies and the rising investments in research and development activities focused on improving HER2 testing capabilities. Overall, the Global HER2 Testing Market is anticipated to witness significant opportunities and advancements in the foreseeable future.
The Global HER2 Testing Market shows varying trends across regions. In Asia, particularly countries like China and India, there is a growing demand for HER2 testing due to the increasing prevalence of breast cancer and improving healthcare infrastructure. North America leads the market with advanced technologies and high awareness levels among both patients and healthcare providers. Europe follows closely with a strong emphasis on personalized medicine and early cancer detection. In the Middle East and Africa region, the market is witnessing steady growth, driven by improving access to healthcare services and rising cancer incidence rates. Latin America is also experiencing growth in HER2 testing market, supported by initiatives to enhance cancer diagnosis and treatment capabilities in the region.
Global HER2 Testing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global HER2 Testing Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global HER2 Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Global HER2 Testing Market - Industry Life Cycle |
3.4 Global HER2 Testing Market - Porter's Five Forces |
3.5 Global HER2 Testing Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global HER2 Testing Market Revenues & Volume Share, By Technique, 2021 & 2031F |
3.7 Global HER2 Testing Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.8 Global HER2 Testing Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Global HER2 Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global HER2 Testing Market Trends |
6 Global HER2 Testing Market, 2021 - 2031 |
6.1 Global HER2 Testing Market, Revenues & Volume, By Technique, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global HER2 Testing Market, Revenues & Volume, By Fluorescence In Situ Hybridization, 2021 - 2031 |
6.1.3 Global HER2 Testing Market, Revenues & Volume, By Dual-Probe, 2021 - 2031 |
6.1.4 Global HER2 Testing Market, Revenues & Volume, By Single-Probe, 2021 - 2031 |
6.1.5 Global HER2 Testing Market, Revenues & Volume, By Chromogenic In Situ Hybridization (CISH), 2021 - 2031 |
6.1.6 Global HER2 Testing Market, Revenues & Volume, By Silver-Enhanced In Situ Hybridization, 2021 - 2031 |
6.2 Global HER2 Testing Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global HER2 Testing Market, Revenues & Volume, By Breast Cancer, 2021 - 2031 |
6.2.3 Global HER2 Testing Market, Revenues & Volume, By Gastric Cancer, 2021 - 2031 |
6.3 Global HER2 Testing Market, Revenues & Volume, By End-user, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global HER2 Testing Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global HER2 Testing Market, Revenues & Volume, By Diagnostic Laboratories, 2021 - 2031 |
6.3.4 Global HER2 Testing Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America HER2 Testing Market, Overview & Analysis |
7.1 North America HER2 Testing Market Revenues & Volume, 2021 - 2031 |
7.2 North America HER2 Testing Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) HER2 Testing Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada HER2 Testing Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America HER2 Testing Market, Revenues & Volume, 2021 - 2031 |
7.3 North America HER2 Testing Market, Revenues & Volume, By Technique, 2021 - 2031 |
7.4 North America HER2 Testing Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.5 North America HER2 Testing Market, Revenues & Volume, By End-user, 2021 - 2031 |
8 Latin America (LATAM) HER2 Testing Market, Overview & Analysis |
8.1 Latin America (LATAM) HER2 Testing Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) HER2 Testing Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil HER2 Testing Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico HER2 Testing Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina HER2 Testing Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM HER2 Testing Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) HER2 Testing Market, Revenues & Volume, By Technique, 2021 - 2031 |
8.4 Latin America (LATAM) HER2 Testing Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
8.5 Latin America (LATAM) HER2 Testing Market, Revenues & Volume, By End-user, 2021 - 2031 |
9 Asia HER2 Testing Market, Overview & Analysis |
9.1 Asia HER2 Testing Market Revenues & Volume, 2021 - 2031 |
9.2 Asia HER2 Testing Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India HER2 Testing Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China HER2 Testing Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan HER2 Testing Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia HER2 Testing Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia HER2 Testing Market, Revenues & Volume, By Technique, 2021 - 2031 |
9.4 Asia HER2 Testing Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
9.5 Asia HER2 Testing Market, Revenues & Volume, By End-user, 2021 - 2031 |
10 Africa HER2 Testing Market, Overview & Analysis |
10.1 Africa HER2 Testing Market Revenues & Volume, 2021 - 2031 |
10.2 Africa HER2 Testing Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa HER2 Testing Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt HER2 Testing Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria HER2 Testing Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa HER2 Testing Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa HER2 Testing Market, Revenues & Volume, By Technique, 2021 - 2031 |
10.4 Africa HER2 Testing Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
10.5 Africa HER2 Testing Market, Revenues & Volume, By End-user, 2021 - 2031 |
11 Europe HER2 Testing Market, Overview & Analysis |
11.1 Europe HER2 Testing Market Revenues & Volume, 2021 - 2031 |
11.2 Europe HER2 Testing Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom HER2 Testing Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany HER2 Testing Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France HER2 Testing Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe HER2 Testing Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe HER2 Testing Market, Revenues & Volume, By Technique, 2021 - 2031 |
11.4 Europe HER2 Testing Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
11.5 Europe HER2 Testing Market, Revenues & Volume, By End-user, 2021 - 2031 |
12 Middle East HER2 Testing Market, Overview & Analysis |
12.1 Middle East HER2 Testing Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East HER2 Testing Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia HER2 Testing Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE HER2 Testing Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey HER2 Testing Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East HER2 Testing Market, Revenues & Volume, By Technique, 2021 - 2031 |
12.4 Middle East HER2 Testing Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
12.5 Middle East HER2 Testing Market, Revenues & Volume, By End-user, 2021 - 2031 |
13 Global HER2 Testing Market Key Performance Indicators |
14 Global HER2 Testing Market - Export/Import By Countries Assessment |
15 Global HER2 Testing Market - Opportunity Assessment |
15.1 Global HER2 Testing Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global HER2 Testing Market Opportunity Assessment, By Technique, 2021 & 2031F |
15.3 Global HER2 Testing Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
15.4 Global HER2 Testing Market Opportunity Assessment, By End-user, 2021 & 2031F |
16 Global HER2 Testing Market - Competitive Landscape |
16.1 Global HER2 Testing Market Revenue Share, By Companies, 2024 |
16.2 Global HER2 Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |